Geron Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 12 2025 Deadline to file Lead Plaintiff Motion.
The Portnoy Law Firm advises Geron Corporation ('Geron' or the 'Company') (NASDAQ: GERN) investors of a class action representing investors that bought securities between February 28, 2024 and February 25, 2025, inclusive (the 'Class Period'). Acadia Healthcare investors have until May 12 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.
The Geron class action lawsuit alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) defendants falsely suggested they possessed reliable information regarding Geron's projected revenue outlook and anticipated growth, while downplaying risks related to seasonality and broader macroeconomic conditions; (ii) in reality, Geron's optimistic portrayals of Rytelo's launch success and growth potential were overstated, as seasonality, existing competition, and the ongoing monitoring requirements had a far greater impact on patient uptake than defendants had indicated; and (iii) Rytelo lacked sufficient market awareness to achieve meaningful penetration, preventing Geron from capitalizing on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside academic medical settings.
The lawsuit further claims that, on February 26, 2025, Geron announced its financial results for the fourth quarter of fiscal year 2024, revealing that Rytelo's growth had stagnated over the prior months. The company attributed the slowed growth to seasonality, competitive pressures, limited awareness of Rytelo, and the burden associated with the drug's required monitoring. Following this announcement, Geron's stock price fell by more than 32%, according to the complaint.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.Admitted CA and NY Bar
[email protected] 310-692-8883
www.portnoylaw.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
reAlpha Tech Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore reAlpha Tech's Fair Values from the Community and select yours reAlpha Tech (NASDAQ:AIRE) Second Quarter 2025 Results Key Financial Results Revenue: US$1.25m (up by US$1.19m from 2Q 2024). Net loss: US$4.11m (loss widened by 178% from 2Q 2024). US$0.08 loss per share (further deteriorated from US$0.033 loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period reAlpha Tech Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) missed analyst estimates by 26%. Looking ahead, revenue is forecast to grow 57% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Software industry in the US. Performance of the American Software industry. The company's shares are up 12% from a week ago. Risk Analysis You should learn about the 6 warning signs we've spotted with reAlpha Tech (including 3 which are significant). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Skift
5 minutes ago
- Skift
Apollo Gives Highside $500 Million to Build Choice's Everhome Suites
The DJIA rose 35 points on Friday, while Nasdaq fell 88, the S&P 500 fell 19 points and the 10-year treasury yield was up .04 to 4.33%. Lodging stocks were mixed. Deutsche Bank predicted that October would be a make-or-break month for sentiment on the hotel REITs. They noted 2Q25 may have had mostly beats, but the majority of the REITs lowered guidance for 3Q below Wall Street estimates while saying they thought 4Q would be the uplifting quarter. DB said they see reasons to believe that, while at the same time, plenty of reasons to be skeptical. The net result is they believe the Hotel REITs are a stock pickers' group, even more than usual. Their top picks remain Ryman Hospitality and Host Hotels. DB lowered price targets on RLJ and Summit Hotels by -$1, to $9 and $8, respectively. Cinnamon Beach Vacations announced that select rental properties are available on Homes & Villas by Marriott
Yahoo
an hour ago
- Yahoo
Workday (NASDAQ:WDAY) Has A Rock Solid Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Workday, Inc. (NASDAQ:WDAY) does use debt in its business. But the more important question is: how much risk is that debt creating? Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Why Does Debt Bring Risk? Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. The first step when considering a company's debt levels is to consider its cash and debt together. How Much Debt Does Workday Carry? The chart below, which you can click on for greater detail, shows that Workday had US$2.99b in debt in April 2025; about the same as the year before. But it also has US$7.97b in cash to offset that, meaning it has US$4.99b net cash. How Healthy Is Workday's Balance Sheet? According to the last reported balance sheet, Workday had liabilities of US$4.82b due within 12 months, and liabilities of US$3.47b due beyond 12 months. On the other hand, it had cash of US$7.97b and US$1.43b worth of receivables due within a year. So it actually has US$1.10b more liquid assets than total liabilities. Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership This state of affairs indicates that Workday's balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So while it's hard to imagine that the US$60.3b company is struggling for cash, we still think it's worth monitoring its balance sheet. Succinctly put, Workday boasts net cash, so it's fair to say it does not have a heavy debt load! Check out our latest analysis for Workday Even more impressive was the fact that Workday grew its EBIT by 130% over twelve months. That boost will make it even easier to pay down debt going forward. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Workday can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts. But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. While Workday has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Happily for any shareholders, Workday actually produced more free cash flow than EBIT over the last two years. That sort of strong cash generation warms our hearts like a puppy in a bumblebee suit. Summing Up While it is always sensible to investigate a company's debt, in this case Workday has US$4.99b in net cash and a decent-looking balance sheet. The cherry on top was that in converted 475% of that EBIT to free cash flow, bringing in US$2.3b. So is Workday's debt a risk? It doesn't seem so to us. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. Be aware that Workday is showing 2 warning signs in our investment analysis , you should know about... If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
